期刊文献+

Occult Hepatitis B Virus Infection: A Killer Hidden in Transfused Blood, Sudan

Occult Hepatitis B Virus Infection: A Killer Hidden in Transfused Blood, Sudan
下载PDF
导出
摘要 Introduction: Transmission of hepatitis B virus (HBV) through the blood is a significant risk, especially in poor countries with high endemicity. Occult transmission of HBV (OBI) is an important acquisition scenario. Objective: A cross-sectional laboratory-based study followed to detect OBI in blood of accepted donors admitted to Mad Medani Blood Bank, Sudan. Methods: During the study, 200 accepted blood units were examined for HBsAg by ELISA technique and negative samples were tested for total anti-HBc antibodies using electroluminescence immunoassay (ECLIAS). HBV DNA amplification was performed for units that showed total anti-Hbc positivity. Results: Of the 200 blood units, 3 appeared positive by ELISA. Total anti-HBc antibodies were present in 34% (67/197) of blood units. HBV DNA was successfully amplified in 52.2% (35/67) of total anti-HBc positive samples. A significant association was observed between reactive total anti-HBc and age group (p Conclusion: OBI was recorded at a high rate in the blood of donors, which necessitates the implementation of detection methods to protect the recipients. Introduction: Transmission of hepatitis B virus (HBV) through the blood is a significant risk, especially in poor countries with high endemicity. Occult transmission of HBV (OBI) is an important acquisition scenario. Objective: A cross-sectional laboratory-based study followed to detect OBI in blood of accepted donors admitted to Mad Medani Blood Bank, Sudan. Methods: During the study, 200 accepted blood units were examined for HBsAg by ELISA technique and negative samples were tested for total anti-HBc antibodies using electroluminescence immunoassay (ECLIAS). HBV DNA amplification was performed for units that showed total anti-Hbc positivity. Results: Of the 200 blood units, 3 appeared positive by ELISA. Total anti-HBc antibodies were present in 34% (67/197) of blood units. HBV DNA was successfully amplified in 52.2% (35/67) of total anti-HBc positive samples. A significant association was observed between reactive total anti-HBc and age group (p Conclusion: OBI was recorded at a high rate in the blood of donors, which necessitates the implementation of detection methods to protect the recipients.
作者 Elhadi Abdalla Ahmed Abdelrahman Eldaw Mohammed Mubarak Ahmed Elshafia Bakri Yousif Mohamed Nour Elhadi Abdalla Ahmed;Abdelrahman Eldaw Mohammed;Mubarak Ahmed Elshafia;Bakri Yousif Mohamed Nour(Department of Medical Microbiology, Faculty of Medical Laboratory Sciences, University of Gezira, Wad Medani, Sudan;Department of Haematology & Immunohaematology, Faculty of Medical Laboratory Sciences, University of Gezira, Wad Medani, Sudan;Department of Medical Parasitology, Faculty of Medical Laboratory Sciences, University of Gezira, Wad Medani,, Sudan)
出处 《Journal of Biosciences and Medicines》 CAS 2022年第10期173-181,共9页 生物科学与医学(英文)
关键词 OBI Blood Donors NESTED-PCR SUDAN OBI Blood Donors Nested-PCR Sudan
  • 相关文献

参考文献3

二级参考文献95

  • 1Korelitz JJ, Busch MP, Kleinman SH, Williams AE, Gilcher RO,Ownby HE, Schreiber GB. A method for estimating hepatitis Bvirus incidence rates in volunteer blood donors. National Heart,Lung, and Blood Institute Retrovirus Epidemiology Donor Study.Transfusion 1997; 37: 634-640 [PMID: 9191825].
  • 2Wang JT, Lee CZ, Chen PJ, Wang TH, Chen DS. TransfusiontransmittedHBV infection in an endemic area: the necessity ofmore sensitive screening for HBV carriers. Transfusion 2002; 42:1592-1597 [PMID: 12473140].
  • 3Candotti D, Allain JP. Transfusion-transmitted hepatitis B virusinfection. J Hepatol 2009; 51: 798-809 [PMID: 19615780 DOI:10.1016/j.jhep.2009.05.020].
  • 4Perkins HA, Busch MP. Transfusion-associated infections:50 years of relentless challenges and remarkable progress.Transfusion 2010; 50: 2080-2099 [PMID: 20738828 DOI: 10.1111/j.1537-2995.2010.02851.x].
  • 5Roth WK, Weber M, Petersen D, Drosten C, Buhr S, Sireis W,Weichert W, Hedges D, Seifried E. NAT for HBV and anti-HBctesting increase blood safety. Transfusion 2002; 42: 869-875 [PMID:12375659].
  • 6Cable R, Lelie N, Bird A. Reduction of the risk of transfusiontransmittedviral infection by nucleic acid amplificationtesting in the Western Cape of South Africa: a 5-year review.Vox Sang 2013; 104: 93-99 [PMID: 22924987 DOI: 10.1111/j.1423-0410.2012.01640.x].
  • 7Raimondo G, Allain JP, Brunetto MR, Buendia MA, Chen DS,Colombo M, Craxì A, Donato F, Ferrari C, Gaeta GB, Gerlich WH,Levrero M, Locarnini S, Michalak T, Mondelli MU, PawlotskyJM, Pollicino T, Prati D, Puoti M, Samuel D, Shouval D, SmedileA, Squadrito G, Trépo C, Villa E, Will H, Zanetti AR, Zoulim F.Statements from the Taormina expert meeting on occult hepatitisB virus infection. J Hepatol 2008; 49: 652-657 [PMID: 18715666DOI: 10.1016/j.jhep.2008.07.014].
  • 8Brojer E, Grabarczyk P, Liszewski G, Mikulska M, Allain JP,Letowska M. Characterization of HBV DNA+/HBsAg- blooddonors in Poland identified by triplex NAT. Hepatology 2006; 44:1666-1674 [PMID: 17133474 DOI: 10.1002/hep.21413].
  • 9Hollinger FB. Hepatitis B virus infection and transfusion medicine:science and the occult. Transfusion 2008; 48: 1001-1026 [PMID:18454738 DOI: 10.1111/j.1537-2995.2008.01701.x].
  • 10Allain JP. Occult hepatitis B virus infection: implications intransfusion. Vox Sang 2004; 86: 83-91 [PMID: 15023176].

共引文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部